(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.54%) $78.90
(-1.28%) $2.17
(0.24%) $2 336.70
(0.17%) $27.66
(0.39%) $968.70
(-0.02%) $0.928
(-0.08%) $10.82
(-0.05%) $0.796
(-0.02%) $91.33
Quarter results tomorrow
(bmo 2024-05-08)
Expected move: +/- 7.59%
3.94% $ 4.22
@ $6.43
Wydano: 14 vas. 2024 @ 22:38
Zwrot: -34.37%
Poprzedni sygnał: vas. 14 - 20:20
Poprzedni sygnał:
Zwrot: -1.30 %
Live Chart Being Loaded With Signals
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 2.22M |
Średni wolumen | 2.62M |
Kapitalizacja rynkowa | 480.31M |
EPS | $0 ( 2024-05-01 ) |
Następna data zysków | ( $-0.480 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.57 |
ATR14 | $0.00800 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Redmile Group, Llc | Buy | 3 636 364 | Pre-Funded Warrants to Purchase Common Stock |
2024-03-04 | Dulac Edward J Iii | Sell | 2 447 | Common Stock |
2024-02-01 | Wolchko J Scott | Buy | 500 000 | Stock Option (Right to Buy) |
2024-02-01 | Tahl Cindy | Buy | 425 000 | Stock Option (Right to Buy) |
2024-02-01 | Dulac Edward J Iii | Buy | 425 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
40.72 |
Last 99 transactions |
Buy: 17 254 718 | Sell: 8 388 589 |
Wolumen Korelacja
Fate Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
STRC | 0.974 |
ONCS | 0.971 |
WISA | 0.97 |
TTCF | 0.969 |
IMRX | 0.968 |
LUMO | 0.964 |
GROM | 0.961 |
VIRX | 0.957 |
MEDS | 0.956 |
IMCC | 0.956 |
10 Najbardziej negatywne korelacje | |
---|---|
NWFL | -0.96 |
IBEX | -0.95 |
MNKD | -0.947 |
PWOD | -0.942 |
LRFC | -0.935 |
HZNP | -0.934 |
PDD | -0.931 |
XOMAO | -0.931 |
ISIG | -0.93 |
IMMR | -0.93 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fate Therapeutics Inc Korelacja - Waluta/Towar
Fate Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $63.53M |
Zysk brutto: | $45.25M (71.22 %) |
EPS: | $-1.640 |
FY | 2023 |
Przychody: | $63.53M |
Zysk brutto: | $45.25M (71.22 %) |
EPS: | $-1.640 |
FY | 2022 |
Przychody: | $96.30M |
Zysk brutto: | $82.54M (85.71 %) |
EPS: | $-2.63 |
FY | 2021 |
Przychody: | $55.85M |
Zysk brutto: | $55.85M (100.00 %) |
EPS: | $-2.24 |
Financial Reports:
No articles found.
Fate Therapeutics Inc
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej